| Primary |
| Hypertonic Bladder |
27.0% |
| Urinary Incontinence |
14.2% |
| Pollakiuria |
11.5% |
| Hypertension |
6.1% |
| Incontinence |
5.1% |
| Urge Incontinence |
4.1% |
| Depression |
3.7% |
| Ill-defined Disorder |
3.7% |
| Micturition Urgency |
3.0% |
| Nocturia |
2.7% |
| Bladder Disorder |
2.4% |
| Cystitis |
2.4% |
| Benign Prostatic Hyperplasia |
2.0% |
| Investigation |
2.0% |
| Myocardial Infarction |
2.0% |
| Diabetes Mellitus |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Fibromyalgia |
1.7% |
| Insomnia |
1.7% |
| Anxiety |
1.4% |
|
| Urinary Retention |
16.8% |
| Nervous System Disorder |
9.6% |
| Death |
8.0% |
| Vision Blurred |
8.0% |
| Drug Ineffective |
4.8% |
| Dry Mouth |
4.8% |
| Hypertension |
4.8% |
| Vomiting |
4.8% |
| Parkinson's Disease |
4.0% |
| Tremor |
4.0% |
| Weight Increased |
4.0% |
| Blood Pressure Increased |
3.2% |
| Cardiac Failure |
3.2% |
| Male Genital Tract Operation |
3.2% |
| Pyelonephritis Acute |
3.2% |
| Urinary Incontinence |
3.2% |
| Urinary Tract Infection |
3.2% |
| Abdominal Pain Upper |
2.4% |
| Amnesia |
2.4% |
| Confusional State |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
22.4% |
| Drug Use For Unknown Indication |
9.7% |
| Hypertension |
9.7% |
| Hypertonic Bladder |
8.7% |
| Urinary Incontinence |
7.6% |
| Cerebral Infarction |
4.6% |
| Anxiety |
3.6% |
| Pollakiuria |
3.6% |
| Urinary Tract Disorder |
3.6% |
| Depression |
3.3% |
| Myocardial Infarction |
3.3% |
| Epilepsy |
3.1% |
| Micturition Urgency |
3.1% |
| Bladder Irritation |
2.3% |
| Bladder Disorder |
2.0% |
| Incontinence |
2.0% |
| Lower Respiratory Tract Infection |
2.0% |
| Pain |
2.0% |
| Atrial Fibrillation |
1.8% |
| Back Pain |
1.8% |
|
| Completed Suicide |
16.7% |
| Death |
8.3% |
| Urinary Retention |
6.7% |
| Constipation |
5.0% |
| Drug Interaction |
5.0% |
| Orthostatic Hypotension |
5.0% |
| Overdose |
5.0% |
| Stevens-johnson Syndrome |
5.0% |
| Strabismus |
5.0% |
| White Blood Cell Count Increased |
5.0% |
| Alcohol Interaction |
3.3% |
| Anuria |
3.3% |
| Cerebral Haemorrhage |
3.3% |
| Cognitive Disorder |
3.3% |
| Disorientation |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Drug Ineffective |
3.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.3% |
| Erythema Multiforme |
3.3% |
| Flatulence |
3.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.8% |
| Product Used For Unknown Indication |
21.8% |
| Hypertension |
6.4% |
| Pain |
5.2% |
| Depression |
5.0% |
| Rheumatoid Arthritis |
3.8% |
| Multiple Sclerosis |
3.4% |
| Parkinson's Disease |
3.0% |
| Diabetes Mellitus |
2.5% |
| Hypertonic Bladder |
2.4% |
| Schizophrenia |
2.4% |
| Osteoporosis |
2.3% |
| Urinary Incontinence |
2.1% |
| Insomnia |
1.8% |
| Asthma |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Prophylaxis |
1.6% |
| Relapsing-remitting Multiple Sclerosis |
1.5% |
| Anxiety |
1.3% |
| Blood Cholesterol Increased |
1.3% |
|
| Vomiting |
17.1% |
| Urinary Tract Infection |
12.2% |
| Weight Decreased |
7.3% |
| Transient Ischaemic Attack |
5.9% |
| Rhabdomyolysis |
4.9% |
| Death |
4.4% |
| Progressive Multifocal Leukoencephalopathy |
4.4% |
| Renal Failure |
4.4% |
| Nausea |
3.9% |
| Tongue Discolouration |
3.9% |
| Tremor |
3.9% |
| Depressed Level Of Consciousness |
3.4% |
| Urinary Retention |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Blood Creatine Increased |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Myalgia |
2.9% |
| Pruritus |
2.9% |
| Pyrexia |
2.9% |
| Weight Increased |
2.9% |
|
| Interacting |
| Anxiety |
17.4% |
| Bladder Irritation |
17.4% |
| Lower Respiratory Tract Infection |
17.4% |
| Depression |
16.3% |
| Pollakiuria |
15.1% |
| Drug Use For Unknown Indication |
11.0% |
| Product Used For Unknown Indication |
2.3% |
| Abdominal Pain Upper |
1.2% |
| Bladder Disorder |
1.2% |
| Prostatism |
0.6% |
|
| Epilepsy |
54.5% |
| Drug Interaction |
18.2% |
| Pollakiuria |
18.2% |
| Weight Increased |
6.1% |
| Orthostatic Hypotension |
3.0% |
|
